Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for early fetal growth restriction
2020-000315-76Phase 2Active
- Sponsor
- Centro Hospitalar Universitário de Lisboa Central
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of enoxaparin sodium in intrauterine growth restriction (IUGR) (2 arms), sponsored by Centro Hospitalar Universitário de Lisboa Central. Primary endpoint: Gestational age at delivery. Started Oct 2021; status: active.
02
Drugs
enoxaparin sodium
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2020-000315-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000315-76.